Multiple Myeloma

Sutro's STRO-001 Receives U.S. FDA Orphan Drug Designation for Treatment of Multiple Myeloma

Sutro Biopharma, Inc.

Cancer Treatment

OncoPep Announces a Phase 1b Clinical Trial of Its Multi-Peptide Cancer Vaccine PVX-410 in Combination with Citarinostat for Smoldering Multiple Myeloma

OncoPep

Positive Opinion

Janssen Receives Positive CHMP Opinion for Darzalex®▼ (daratumumab) as Frontline Treatment for Newly Diagnosed Patients with Multiple Myeloma

Janssen Pharmaceutical Companies

Collaboration

Amgen And MD Anderson Announce Collaboration To Accelerate Early Stage Treatments For Cancer

Amgen

Janssen Announces Initiation of Phase 1b/2 Clinical Development Program Evaluating JNJ-68284528 CAR-T Cells for the Treatment of Multiple Myeloma

Janssen Pharmaceutical Companies